AR017676A1 - Derivado seudopolimorfico de dihidrocloruro del acido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acetico, procedimiento para su preparacion y composicion farmaceutica que lo comprende - Google Patents

Derivado seudopolimorfico de dihidrocloruro del acido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acetico, procedimiento para su preparacion y composicion farmaceutica que lo comprende

Info

Publication number
AR017676A1
AR017676A1 ARP980105975A ARP980105975A AR017676A1 AR 017676 A1 AR017676 A1 AR 017676A1 AR P980105975 A ARP980105975 A AR P980105975A AR P980105975 A ARP980105975 A AR P980105975A AR 017676 A1 AR017676 A1 AR 017676A1
Authority
AR
Argentina
Prior art keywords
piperazinyl
fluorophenyl
bis
methyl
acetic
Prior art date
Application number
ARP980105975A
Other languages
English (en)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of AR017676A1 publication Critical patent/AR017676A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Formas pseudopolimorficas derivadas del dihidrocloruro del ácido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acético a saber, anhídrico deldihidrocloruro del ácido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acético, cuyo patron de difraccion de Rayos X presenta picos a valores de 2theta de: 13,710,5; 13,910,5; 16,310,5; 18,010,5; 18,60,5; 19,110,5; 23,110,5; 24,110,5; 25,610,5; y 30,210,5; y monohidrato deldihidrocloruro del ácido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acético, cuyo patron de difraccion de Rayos X presenta picos a valores de 2theta de: 7,510,5; 9,710,5; 10,510,5; 10,710,5; 15,710,5; 18,910,5; 19,610,5; 19,910,5; 20,410,5; 20,910,5; 22,210,5; 22,510,5;24,610,5; 24,710,5; 25,910,5; y 29,310,5. El ácido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acético, también conocido y denominado en losucesivo efletirizina es el compuesto de la formula (I). Este compuesto posee excelentes propiedades antihistamínicas. Pertenece a la clasefarmacologica deantagonistas del receptor H1 de la histamina de segunda generacion y muestra alta afinidad in vitro y selectividad por los receptores H1. Procedimientos parala preparacion de estas formas pseudopolimorficas y composiciones farmacéuticas que las contienen.
ARP980105975A 1997-11-26 1998-11-25 Derivado seudopolimorfico de dihidrocloruro del acido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acetico, procedimiento para su preparacion y composicion farmaceutica que lo comprende AR017676A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (en) 1997-11-26 1997-11-26 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride

Publications (1)

Publication Number Publication Date
AR017676A1 true AR017676A1 (es) 2001-09-12

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105975A AR017676A1 (es) 1997-11-26 1998-11-25 Derivado seudopolimorfico de dihidrocloruro del acido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acetico, procedimiento para su preparacion y composicion farmaceutica que lo comprende

Country Status (39)

Country Link
US (2) US6262057B1 (es)
EP (2) EP0919550A1 (es)
JP (2) JP3996348B2 (es)
KR (1) KR100557711B1 (es)
CN (1) CN100406448C (es)
AR (1) AR017676A1 (es)
AT (1) ATE203237T1 (es)
AU (1) AU735819B2 (es)
BG (1) BG64155B1 (es)
BR (1) BR9815405A (es)
CA (1) CA2310318C (es)
CO (1) CO4980892A1 (es)
CZ (1) CZ295972B6 (es)
DE (1) DE69801163T2 (es)
DK (1) DK1034171T3 (es)
EG (1) EG23776A (es)
ES (1) ES2161552T3 (es)
GC (1) GC0000094A (es)
GR (1) GR3036702T3 (es)
HU (1) HUP0100343A3 (es)
ID (1) ID24964A (es)
IL (1) IL135544A (es)
MA (1) MA26569A1 (es)
MY (1) MY119653A (es)
NO (1) NO314692B1 (es)
NZ (1) NZ504461A (es)
PE (1) PE134899A1 (es)
PL (1) PL190871B1 (es)
PT (1) PT1034171E (es)
RS (1) RS49904B (es)
RU (1) RU2182575C2 (es)
SI (1) SI20325A (es)
SK (1) SK283237B6 (es)
TN (1) TNSN98214A1 (es)
TR (1) TR200001505T2 (es)
TW (1) TWI225053B (es)
UA (1) UA54568C2 (es)
WO (1) WO1999028310A1 (es)
ZA (1) ZA9810780B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047689A2 (en) * 2000-12-15 2002-06-20 Ucb, S.A. Use of cetirizine or efletirizine for preventing urticaria
WO2003009849A1 (en) * 2001-07-26 2003-02-06 Ucb, S.A. Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
JP2007500197A (ja) * 2003-05-28 2007-01-11 ユセベ ファルシム ソシエテ アノニム 持続性アレルギー性鼻炎の治療のためのエフレチリジンの使用
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2008155777A2 (en) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Process for preparing efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
UA8337A1 (uk) * 1981-02-06 1996-03-29 Бальтес Ежен 2-[4-(дифенілметіл)-1-піперазиніл]-оцтові кислоти або їх аміди, або їх нетоксичні фармацевтично прийняті солі, що проявляють спазмолітичну і антигістамінну активність
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.

Also Published As

Publication number Publication date
EG23776A (en) 2007-08-08
YU31600A (sh) 2002-03-18
ATE203237T1 (de) 2001-08-15
MY119653A (en) 2005-06-30
CN1279676A (zh) 2001-01-10
TNSN98214A1 (fr) 2005-03-15
AU1327799A (en) 1999-06-16
US6335331B2 (en) 2002-01-01
GR3036702T3 (en) 2001-12-31
JP2001524548A (ja) 2001-12-04
ES2161552T3 (es) 2001-12-01
IL135544A (en) 2004-02-08
BG104424A (en) 2001-01-31
US20010021712A1 (en) 2001-09-13
PE134899A1 (es) 2000-01-11
PT1034171E (pt) 2001-11-30
CZ295972B6 (cs) 2005-12-14
ZA9810780B (en) 1999-05-31
AU735819B2 (en) 2001-07-19
CN100406448C (zh) 2008-07-30
RS49904B (sr) 2008-08-07
NO20002631D0 (no) 2000-05-23
HUP0100343A3 (en) 2001-09-28
NZ504461A (en) 2001-06-29
PL340724A1 (en) 2001-02-26
RU2182575C2 (ru) 2002-05-20
KR20010032420A (ko) 2001-04-16
GC0000094A (en) 2005-06-29
EP0919550A1 (en) 1999-06-02
CA2310318C (en) 2003-10-21
CO4980892A1 (es) 2000-11-27
JP3996348B2 (ja) 2007-10-24
NO314692B1 (no) 2003-05-05
EP1034171B1 (en) 2001-07-18
CZ20001787A3 (cs) 2000-09-13
MA26569A1 (fr) 2004-12-20
HUP0100343A2 (hu) 2001-07-30
DK1034171T3 (da) 2001-11-05
BR9815405A (pt) 2000-10-10
DE69801163D1 (en) 2001-08-23
UA54568C2 (uk) 2003-03-17
ID24964A (id) 2000-08-31
JP2007224042A (ja) 2007-09-06
PL190871B1 (pl) 2006-02-28
SK283237B6 (sk) 2003-04-01
SK5942000A3 (en) 2000-10-09
EP1034171A1 (en) 2000-09-13
IL135544A0 (en) 2001-05-20
DE69801163T2 (de) 2002-03-28
KR100557711B1 (ko) 2006-03-07
CA2310318A1 (en) 1999-06-10
BG64155B1 (bg) 2004-02-27
TR200001505T2 (tr) 2000-09-21
WO1999028310A1 (en) 1999-06-10
TWI225053B (en) 2004-12-11
US6262057B1 (en) 2001-07-17
SI20325A (sl) 2001-02-28
NO20002631L (no) 2000-05-23

Similar Documents

Publication Publication Date Title
BR0213350A (pt) Derivados benzoxazina e benzotiazina e composições farmacêuticas contendo os mesmos
DE69828445D1 (de) Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
YU60701A (sh) Nova triciklička jedinjenja i njihova upotreba u medicini; postupak za njihovo pripremanje i farmaceutske kompozicije koje ih sadrže
DE60217118D1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
ATE306261T1 (de) Antithrombosemittel
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
ATE297203T1 (de) Antithrombotische mitteln
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
FI970317A (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
BR0010139A (pt) Heterociclos bicìclicos substituìdos, processo para seu preparo e seu uso como agentes anti-obesidade e hipocolesterolêmico
ES2036926A1 (es) "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
AR017676A1 (es) Derivado seudopolimorfico de dihidrocloruro del acido 2-[2-[4-[bis(4-fluorofenil)metil]-1-piperazinil]etoxi]acetico, procedimiento para su preparacion y composicion farmaceutica que lo comprende
ATE15662T1 (de) Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
IL69340A0 (en) Phenothiazine derivatives,their preparation and pharmaceutical compositions containing them
ES2077354T3 (es) Derivados de 2-hidroxi-2-feniletilamina utiles como agonistas de beta-3-adrenoceptores.
DK601683A (da) Dialkylaminoalkoxybenzylalkoholderivater
DK320485A (da) Ether-oxid-derivater af cyclopropylphenoler, deres fremstilling oganvendelse
DK152053C (da) Analogifremgangsmaade til fremstilling af anthracyclinglycosider eller deres farmaceutiske acceptable syreadditionssalte
BR9812770A (pt) Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos
AU2042795A (en) Pyrimidine derivatives and pharmaceutical composition
SE8903312D0 (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
BR0114888A (pt) Derivados de triazol e composições farmacêuticas compreendendo os mesmos
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat

Legal Events

Date Code Title Description
FC Refusal